Thrombophilic factors in patients with Syndrome X.
Terpos
E
E
Athanasiou
A
A
Tsoukala
C
C
Anastasopoulou
J
J
Kyriakidis
M
M
Karafoulidou
A
A
D020016:Activated Protein C Resistance / Q000097:blood; D000990:Antithrombin III / Q000378:metabolism; D001779:Blood Coagulation Factors / Q000378:metabolism*; D016022:Case-Control Studies; D004797:Enzyme-Linked Immunosorbent Assay; D005167:Factor VII / Q000378:metabolism; D005169:Factor VIII / Q000378:metabolism; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D008297:Male; D017566:Microvascular Angina / Q000097:blood*; D008875:Middle Aged; D010958:Plasminogen / Q000378:metabolism; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D011486:Protein C / Q000378:metabolism; D017293:Protein S / Q000378:metabolism; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood; D010959:Tissue Plasminogen Activator / Q000097:blood; D014841:von Willebrand Factor / Q000378:metabolism
D001779:Blood Coagulation Factors; D017395:Plasminogen Activator Inhibitor 1; D011486:Protein C; D017293:Protein S; D014841:von Willebrand Factor; D000990:Antithrombin III; D005167:Factor VII; D005169:Factor VIII; D005340:Fibrinogen; D010958:Plasminogen; D010959:Tissue Plasminogen Activator